Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.66 CNY -0.91%
Market Cap: 101.3B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note

Relative Value

The Relative Value of one Shanghai RAAS Blood Products Co Ltd stock under the Base Case scenario is 7.54 CNY. Compared to the current market price of 7.66 CNY, Shanghai RAAS Blood Products Co Ltd is Overvalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
7.54 CNY
Overvaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
56
Median 3Y
12.6
Median 5Y
14.4
Industry
8.1
Forward
11.7
vs History
47
vs Industry
6
Median 3Y
52.1
Median 5Y
57.2
Industry
23
Forward
41.1
vs History
9
vs Industry
6
Median 3Y
50.5
Median 5Y
68.5
Industry
23.4
vs History
3
vs Industry
5
Median 3Y
62.2
Median 5Y
81.9
Industry
27.3
vs History
52
vs Industry
47
Median 3Y
3.1
Median 5Y
3.4
Industry
2.6
vs History
74
vs Industry
50
Median 3Y
12.2
Median 5Y
13.8
Industry
8.1
Forward
11.3
vs History
57
vs Industry
29
Median 3Y
28.6
Median 5Y
31.5
Industry
9.6
vs History
79
vs Industry
6
Median 3Y
43.6
Median 5Y
52.9
Industry
4.3
Forward
33
vs History
79
vs Industry
6
Median 3Y
43.6
Median 5Y
52.9
Industry
3.8
Forward
34.6
vs History
11
vs Industry
7
Median 3Y
48.1
Median 5Y
66.5
Industry
6
vs History
3
vs Industry
5
Median 3Y
59.4
Median 5Y
79
Industry
3.8
vs History
53
vs Industry
48
Median 3Y
3.4
Median 5Y
3.6
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Shanghai RAAS Blood Products Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
102.2B CNY 12.3 57.4 42.5 42.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Average P/E: 187.3
57.4
68%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Average EV/EBITDA: 21.5
42.5
54%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Average EV/EBIT: 26.1
42.5
47%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top